- Home
- CLBT
CLBT
Cellebrite DI Ltd.
as 06-20-2025 4:00pm EST
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
| Founded: | 1999 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.1B | IPO Year: | N/A |
| Target Price: | $22.43 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.47 - $26.30 | Next Earning Date: | 08-14-2025 |
| Revenue: | $419,170,000 | Revenue Growth: | 22.04% |
| Revenue Growth (this year): | 20.75% | Revenue Growth (next year): | 17.32% |
Latest Cellebrite DI Ltd. News
CLBT Breaking Stock News: Dive into CLBT Ticker-Specific Updates for Smart Investing
Insider Monkey
16 days ago
Cellebrite DI Ltd. (CLBT) to Acquire Corellium
GlobeNewswire
16 days ago
Cellebrite to Acquire Corellium
Yahoo Finance Video
20 days ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
20 days ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
GlobeNewswire
20 days ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
GlobeNewswire
20 days ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
CNW Group
20 days ago
Statement by Minister Guilbeault on Portuguese Heritage Month
Moneywise
20 days ago
‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins
Compare CLBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLBT Cellebrite DI Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.